INSMED INC Prepaid Expense and Other Assets, Current
INSMED INC (INSM) had Prepaid Expense and Other Assets, Current of $115.90 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $115.90M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $78.19M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $91.24M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $65.60M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $115.90M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $78.19M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $91.24M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $65.60M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $62.18M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $54.78M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $37.24M 10-K · filed 2026-02-19 |
| 2024-09-30 | $41.15M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $41.02M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $42.87M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $24.18M 10-K · filed 2025-02-20 |
| 2023-09-30 | $27.12M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $26.36M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $28.54M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $25.47M 10-K · filed 2024-02-22 |
| 2022-09-30 | $25.19M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $23.36M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $31.15M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $28.90M 10-K · filed 2023-02-23 |
| 2021-09-30 | $25.66M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $31.07M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $21.57M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $23.98M 10-K · filed 2022-02-17 |
| 2020-09-30 | $19.72M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $14.76M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.77M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $20.22M 10-K · filed 2021-02-25 |
| 2019-09-30 | $21.31M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $15.86M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $12.37M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $11.33M 10-K · filed 2020-02-25 |
| 2018-09-30 | $9.92M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $10.93M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $9.83M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $8.28M 10-K · filed 2019-02-22 |
| 2017-09-30 | $6.80M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $5.47M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $5.79M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $5.82M 10-K · filed 2018-02-23 |
| 2016-09-30 | $5.78M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $6.20M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $5.62M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $5.24M 10-K · filed 2017-02-23 |
| 2015-09-30 | $8.29M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $7.06M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $5.69M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $5.49M 10-K · filed 2016-02-25 |
| 2014-09-30 | $3.53M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $4.01M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $4.96M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $2.27M 10-K · filed 2015-02-27 |
| 2013-09-30 | $1.72M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.78M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $1.42M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $643.00K 10-K · filed 2014-03-06 |
| 2012-09-30 | $605.00K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $715.00K 10-Q · filed 2012-08-07 |
| 2011-12-31 | $370.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |